ISSN:
1432-2072
Keywords:
5-HT receptor
;
Sumatriptan
;
Prolactin
;
Cortisol
;
Growth hormone
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract The neuroendocrine effects of the 5-HT receptor agonist, sumatriptan (6 mg subcutaneously), were studied in 11 healthy male subjects using a placebo-controlled, cross-over design. Compared to placebo, sumatriptan significantly lowered levels of plasma prolactin but increased those of plasma growth hormone. There was no effect on plasma cortisol concentrations. The neuroendocrine effects of sumatriptan differ from those of previously described 5-HT-receptor agonists, and may be a consequence of selective activation of 5-HT1D or 5-HT1B receptors. However, the present data cannot exclude the possibility that the neuroendocrine changes reflect non-specific stress responses or changes in pituitary blood flow.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF02245240
Permalink